*  Combination Chemotherapy in Treating Patients With Breast Cancer - Full Text View - ClinicalTrials.gov
OBJECTIVES: I. Compare the sequential chemotherapy with doxorubicin, paclitaxel and cyclophosphamide to combined doxorubicin ... Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin Modulators. Antimitotic Agents. Mitosis Modulators. Molecular ... patients may have had either an axillary node dissection or sentinel lymph node biopsy before beginning treatment on protocol. ... Antineoplastic Agents, Alkylating. Alkylating Agents. Myeloablative Agonists. Antibiotics, Antineoplastic. Topoisomerase II ...
  https://www.clinicaltrials.gov/ct2/show/NCT00003088
*  Phase II study of sorafenib in co... preview & related info | Mendeley
PURPOSE: The combination of sorafenib with chemotherapy is well-tolerated and is associated with encouraging response rates in ... Antineoplastic Combined Chemotherapy Protocols. *Antineoplastic Combined Chemotherapy Protocols: th. *Benzenesulfonates. * ... A phase II study was conducted to determine the efficacy and toxicity of combined sorafenib, docetaxel, and cisplatin in ... PURPOSE: The combination of sorafenib with chemotherapy is well-tolerated and is associated with encouraging response rates in ...
  https://www.mendeley.com/research-papers/phase-ii-study-sorafenib-combination-docetaxel-cisplatin-treatment-metastatic-advanced-gastric-gastr/
*  Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer - Full Text View -...
Antineoplastic Combined Chemotherapy Protocols. Paclitaxel. Cisplatin. Additional relevant MeSH terms: Lung Neoplasms. Small ... Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin Modulators. Antimitotic Agents. Mitosis Modulators. Molecular ... Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer. The safety and ... Effect of Chemotherapy With Paclitaxel and Cisplatin on Development Dysgeusia in Non-small Cell Lung Cancer Patients. ...
  https://clinicaltrials.gov/ct2/show/NCT01540045?cond=%22Lung+Neoplasms%22&rank=17
*  Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute...
Keywords : Leukemia, lymphoid; Antineoplastic combined chemotherapy protocols; Immunization; Viral vaccines; Child. · text in ... RESULTS: After chemotherapy, 75.9%, 67.9%, 59.3% and 51.7% of the patients showed low antibody titers that would be unlikely to ... OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after ... Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute ...
  http://www.scielo.br/scielo.php?script=sci_abstract&pid=S1516-84842012000400011&lng=en&nrm=iso&tlng=en
*  Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death.
Antineoplastic Combined Chemotherapy Protocols / pharmacology*. Cell Death / drug effects. Cells, Cultured. Dose-Response ... The role of IRS1 and IRS2 in controlling cell responses to chemotherapy is unknown. To determine the role of IRS1 and IRS2 in ... We found that expression of IRS1, in contrast to IRS2, enhanced the sensitivity of 32D cells to chemotherapy-induced apoptosis ... Decreasing Annexin A2 levels reduced 32D-IRS1 cell sensitivity to chemotherapy. These results suggest IRS1 enhances sensitivity ...
  http://www.biomedsearch.com/nih/Insulin-receptor-substrate-1-expression/22652453.html
*  Program Members > Yale Cancer Center | Yale School of...
Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Head and Neck Neoplasms ...
  https://medicine.yale.edu/cancer/patient/programs/thoracic/members/
*  Program Members
Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Head and Neck Neoplasms ...
  http://www.yalecancercenter.org/patient/programs/thoracic/members/
*  Dan-Arin Silasi, MD | Yale School of Medicine
Antineoplastic Combined Chemotherapy Protocols. *Pelvic Exenteration. *Pelvic Neoplasms. *Chemotherapy, Cancer, Regional ... In Combination With And/or Following Chemotherapy In Patients With Previously Untreated Epithelial Ovarian Cancer ... or Primary Peritoneal Cancer That Have Received at Least 2 Prior Lines of Chemotherapy ... Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, ...
  http://medicine.yale.edu/intranet/facultybydept/dan-arin_silasi-3.profile
*  Gynecologic Oncology > Yale Cancer Center | Yale School of...
Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colposcopy; Cytoreduction Surgical Procedures; ...
  https://medicine.yale.edu/cancer/patient/people/gynonc.aspx
*  Plus it
Antineoplastic combined chemotherapy protocols. With the important exception of the E4599 trial of bevacizumab in conjunction ... Trials combining cetuximab with chemotherapy have shown a trend to increased response rate and prolonged progression-free ... ATLAS is a phase III trial of bevacizumab with chemotherapy followed by erlotinib after chemotherapy is completed that will ... that combined novel agents with standard chemotherapy have produced disappointing or equivocal results. Many agents identified ...
  http://clincancerres.aacrjournals.org/content/13/15/4583s
*  Treatment of breast cancer during pregnancy: an observational study.
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*. Apgar Score. Birth Weight / drug effects*. Breast Neoplasms ... Previous Document: Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniq.... ... INTERPRETATION: Although our data show that infants exposed to chemotherapy in utero had a lower birthweight at gestational age ... Birthweight was affected by chemotherapy exposure after adjustment for gestational age (p=0·018), but not by number of ...
  http://www.biomedsearch.com/nih/Treatment-breast-cancer-during-pregnancy/22902483.html
*  Quality control of end results in a Danish adjuvant breast cancer multi-center study.
In the two protocols 4455 patients were randomized and 2477 were registered off-study. Dat ... quality control was performed on off-study data for high-risk breast cancer patients included in protocols of adjuvant therapy ... Antineoplastic Combined Chemotherapy Protocols / therapeutic use*. Breast Neoplasms / drug therapy*, epidemiology, mortality. ... Chemotherapy, Adjuvant. Denmark / epidemiology. Disease-Free Survival. Female. Humans. Neoplasm Recurrence, Local*. Quality ...
  http://www.biomedsearch.com/nih/Quality-control-end-results-in/9490088.html
*  A case report of primary small cell carcinoma of the breast and review of the literature.
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Breast Neoplasms / drug therapy, metabolism, pathology*, ... including chemotherapy, radiotherapy, and endocrine therapy alone or in combination, should be determined according to ... effective option seems to be modified radical mastectomy with axillary lymph node dissection followed by adjuvant chemotherapy ...
  http://www.biomedsearch.com/nih/case-report-primary-small-cell/22516480.html
*  Primary laryngeal lymphoma: report of 3 cases and review of the literature.
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biopsy, Needle. Combined Modality Therapy. Fatal Outcome. ...
  http://www.biomedsearch.com/nih/Primary-laryngeal-lymphoma-Report-three/19378323.html
*  Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer.
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*. Breast Neoplasms / drug therapy, pathology*. Carcinoma, ... from 30 patients with MBC starting with a new line of chemotherapy.. RESULTS: The number of CTC was found to be significantly ... in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: the SUCCESS ... 2008Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of ...
  http://www.biomedsearch.com/nih/Circulating-tumour-cells-in-central/21468046.html
*  Academic Programs Faculty - Last Initial L - Wake Forest School of Medicine
Lymphoma, Non-Hodgkin; Antineoplastic Combined Chemotherapy Protocols; Hemangiopericytoma; Meningioma; Antiretroviral Therapy, ... Peritoneal Neoplasms; Hyperthermia, Induced; Chemotherapy, Cancer, Regional Perfusion; Adenocarcinoma; Antineoplastic Combined ... Carcinoma, Lobular; Biopsy; Antineoplastic Agents; Breast Neoplasms; Chemoprevention Academic: 336-716-4316. Department: 336- ... Brain Neoplasms; Glioma; Glioblastoma; Central Nervous System Neoplasms; Antineoplastic Agents Academic: 336-716-9527. ...
  http://www.wakehealth.edu/School/FacultySR.htm?st=L&li=L&ft=R
*  Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines.
Antineoplastic Agents / administration & dosage, pharmacology, therapeutic use. Antineoplastic Combined Chemotherapy Protocols ... Chemotherapy in gastric cancerAnticancer ResYear: 20082821213121918505058. Goyle S,Maraveyas A,Chemotherapy for colorectal ... However, combined administration of GA and Doc provided a synergistic effect on growth suppression of MKN-28 cells. Based on ... The concentration ratio for the combined application of GA and Doc was set as 1: 2.5, which is approximately the same as the ...
  http://www.biomedsearch.com/nih/Synergistic-anti-proliferative-effects-gambogic/22546220.html
*  The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A...
Antineoplastic Combined Chemotherapy Protocols / administration & dosage, therapeutic use*. Child. Child, Preschool. Female. ... Of 19 evaluable patients presenting with a neurologic deficit and treated with primary chemotherapy, recovery was completed in ... CONCLUSIONS: By treating patients with dumbbell neuroblastoma initially with chemotherapy, the authors were able to reduce the ... The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A ...
  http://www.biomedsearch.com/nih/treatment-neuroblastoma-with-intraspinal-extension/8674009.html
*  Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer.
Antineoplastic Combined Chemotherapy Protocols / adverse effects, therapeutic use. Carcinoma, Squamous Cell / pathology, ... Chemotherapy, Adjuvant. Cisplatin / adverse effects, therapeutic use. Diarrhea / chemically induced, etiology. Dose ... Ten days after radiation therapy, TP regimen was administered as adjuvant chemotherapy.. RESULTS: For the experimental and ... 19648826 - Accuracy and complexities of using automated clinical data for capturing chemotherapy a.... 11768566 - Practical ...
  http://www.biomedsearch.com/nih/Efficacy-concurrent-chemoradiotherapy-plus-adjuvant/20979696.html
*  Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus...
Antineoplastic Combined Chemotherapy Protocols / adverse effects, therapeutic use*. Breast Neoplasms / drug therapy*, ... Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus ...
  http://www.biomedsearch.com/nih/Acknowledgement-reviewers-2013/24292815.html
*  astrocytic tumor spinal cord 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Antineoplastic Combined Chemotherapy Protocols. Biomarkers, Tumor / analysis. Biomarkers, Tumor / metabolism. Chorionic ... Chemotherapy was administered and follow-up spine MRI at 2 months did not reveal any residual tumor, however, the ... MeSH-major] Antineoplastic Agents, Alkylating / therapeutic use. Astrocytoma / drug therapy. Astrocytoma / metabolism. ... Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 7GR28W0FJI / Dacarbazine; 85622-93-1 / temozolomide; EC 2.1. ...
  http://www.bmlsearch.com/?kwr=astrocytic+tumor+spinal+cord+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
*  adult anaplastic oligoastrocytoma 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Antineoplastic Combined Chemotherapy Protocols. Chemotherapy, Adjuvant. Cranial Irradiation. Craniotomy. Fatal Outcome. Female ... Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cell Transformation, Neoplastic. Diagnosis, Differential. ... Antineoplastic Agents / administration & dosage. Antineoplastic Agents / adverse effects. Chemotherapy, Adjuvant / methods. ... Chemotherapy, Adjuvant. Combined Modality Therapy. Dacarbazine / administration & dosage. Dacarbazine / analogs & derivatives. ...
  http://www.bmlsearch.com/?kwr=adult+anaplastic+oligoastrocytoma+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
*  administration and dosage - CISMeF
antineoplastic combined chemotherapy protocols. antineoplastic agents. chemotherapy-induced nausea and vomiting. risk factors. ... antineoplastic combined chemotherapy protocols. MPT Regimen. multiple myeloma. aged. aged, 80 and over. melphalan. thalidomide ... Chemotherapy-induced neutropenia (disorder). immunization schedule. infection. guidelines for drug use. Chemotherapy. ... antimetabolites, antineoplastic. practice guideline. fluorouracil. fluorouracil. antimetabolites, antineoplastic. Capecitabine ...
  http://www.chu-rouen.fr/page/detail/en/MSH_Q_000008
*  Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours - Publikationsserver der Universität...
Antineoplastic Agents/pharmacology. MESH. Antineoplastic Combined Chemotherapy Protocols/therapeutic use. MESH. Cell Division/ ...
  https://epub.uni-regensburg.de/4758/